New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export SNY’s income statement to Excel — free account
Sanofi
SNYHealthcare Drug Manufacturers General
Sanofi’s revenue for fiscal 2025 (year ended December 2025) was $52.9 billion, up 10.3% from fiscal 2024.
- Revenue
- +13.9%
- EPS
- +8.21%
- Free cash flow
- +99.6%
- Total debt
- −11.2%
Quarter to September 2026, against a year earlier
46.59
0.53
+1.15%
Follow SNY
Alert me
What it owns vs. what it owes Q3 FY2026, Sep 30, 2026
It owes $13.8B more in debt than it holds in cash and short-term investments. Shareholders’ equity is 56.2% of the balance sheet. What is a balance sheet?
Owns
$111.7BLong-term assets
$31.4BOther short-term assets
$6.9BCash & short-term investments
Funded by
$84.3BShareholders’ equity
$45.0BOther liabilities
$20.7BDebt
Debt is 13.8% of the total; shareholders’ equity 56.2%.
Net debt has held near 9% of assets since Q4 FY25.
Net debt ÷ assets (right axis)
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Total assets | $143.5B | $149.8B | $150.1B | $150.0B |
| Net debt (debt less cash) | $12.4B | $14.8B | $17.8B | $13.8B |
| Net debt ÷ assets (right axis) | 8.6% | 9.9% | 11.9% | 9.2% |
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
6,866.87 | 7,383.15 | 6,488.70 | 8,663.13 |
+8 more quarters Free account |
Receivables |
375.23 | 10,703.82 | 564.13 | 9,964.24 | |
Inventory |
28,801.47 | 12,937.36 | 27,507.91 | 11,556.12 | |
Other current assets |
— | 4,978.68 | — | 4,600.27 | |
Total current assets |
38,221.26 | 36,650.63 | 35,303.95 | 35,019.09 | |
Property, Plant, Equpment (Net) |
12,094.71 | 12,050.22 | 11,887.75 | 11,372.83 | |
Long-Term Investments |
— | 3,728.78 | — | 3,687.23 | |
Goodwill and Intangible Assets (Total) |
77,837.52 | 79,427.52 | 80,858.26 | 76,438.52 | |
Long Term Assets (Tax, Deferred) |
— | 10,188.74 | — | 9,739.09 | |
Long-term assets (Other) |
20,002.08 | 6,163.47 | 20,013.84 | 5,559.70 | |
Total non-current assets |
111,739.10 | 113,407.40 | 114,535.30 | 108,448.10 | |
Total Assets |
149,960.30 | 150,058.10 | 149,839.30 | 143,467.20 | |
Accounts Payable |
28,260.50 | 8,313.31 | 26,577.44 | 8,328.24 | |
Current Part of Debt |
3,854.70 | 8,169.13 | 6,929.94 | 4,912.54 | |
Current Part of Taxes to Pay |
1,644.78 | 1,027.83 | 1,102.52 | 849.68 | |
Other current liabilities |
253.22 | 19,121.76 | — | 17,610.24 | |
Total current liabilities |
34,261.82 | 37,125.01 | 35,121.36 | 32,069.53 | |
Long Term Debt (Total) |
16,796.54 | 17,028.90 | 14,393.58 | 16,120.19 | |
Long Term Tax Liability (Deferred) |
1,810.52 | 1,805.67 | 1,896.05 | 1,884.91 | |
Non-current Liabilities (Other) |
10,849.33 | 11,263.07 | 11,016.98 | 10,600.09 | |
Total non-current liabilities |
31,398.13 | 32,047.50 | 29,111.36 | 30,264.95 | |
Total liabilities |
65,659.95 | 69,172.51 | 64,232.72 | 62,334.48 | |
Additional Paid In Capital |
— | — | — | 1.13 | |
Common Stock (Net) |
— | 2,823.04 | — | 2,759.49 | |
Retained Earnings |
— | 73,864.01 | — | 75,664.64 | |
Treasury Stock |
— | 1,604.53 | — | 1,212.86 | |
Common Equity (Total) |
— | 80,885.55 | — | 81,132.70 | |
Shareholders Equity (Total) |
84,300.39 | 80,885.55 | 85,606.57 | 81,132.70 | |
Shareholders Equity and Liabilities (Total) |
149,960.30 | 150,058.10 | 149,839.30 | 143,467.20 | |
Shares (Common) |
— | 2,428.20 | — | 2,439.00 | |
Shareholders Equity (Tangible) |
6,462.88 | 1,458.03 | 4,748.32 | 4,694.17 | |
Net Debt |
13,784.37 | 17,814.89 | 14,834.82 | 12,369.60 | |
Total Debt |
20,651.24 | 25,198.03 | 21,323.52 | 21,032.73 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 5, 2026